Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of PDE5 Inhibition on Adipose Metabolism in Humans
Sponsor: Vanderbilt University Medical Center
Summary
This is a randomized, double-blinded, placebo-controlled study of the effects of PDE5 inhibition with tadalafil on adipose tissue in obese individuals. Adipose metabolism will be measured using magnetic resonance imaging (MRI) scans and by aspirating a small amount of adipose to measure gene expression.
Key Details
Gender
All
Age Range
19 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
89
Start Date
2021-03-16
Completion Date
2025-06-24
Last Updated
2026-06-18
Healthy Volunteers
Yes
Conditions
Interventions
Tadalafil 20 MG
Tadalafil is an FDA approved, clinically-available drug that inhibits the enzyme phosphodiesterase type 5A (PDE5). Subjects who are randomized to this arm will be provided with 20mg of Tadalafil to take every day for 12 weeks, beginning at their baseline visit.
Placebo
Subjects in this arm will be provided with 20mg Placebo to take every day for 12 weeks, beginning at their baseline visit.
Locations (1)
Vanderbilt University Medical Center
Nashville, Tennessee, United States